UpdateMaker is shareware. If you make practical use of it beyond just trying it out, you should send us US$10 if you are only making private use of it, and US$50 if you wish to make commercial use of it. This charge is for a single-user license. Large companies who would like site licenses to cover many users and locations should contact us. Please send cheques to:
AD Instruments,
Suite H, 2251 Grant Rd,
Los Altos CA94024,
United States.
This will entitle you to feel smug for at least a week afterwards. This address cannot provide support for UpdateMaker. If you have questions about UpdateMaker, please use electronic mail to the Internet address below. We will fix bugs (when I can find them...), and new versions of UpdateMaker will be distributed from time to time over the Internet, but we cannot at present afford to notify users individually of this.
This software may not be sold or distributed for profit, or included with other software which is sold or distributed for profit, without the permission of the author. Offenders will be proceeded against in the High Court by mesne process and writ of ne exeat regno with barratry and replevin, notwithstanding the dicta of Wright LJ in Rainham Chemical Works Ltd v Belvedere Fish Guano Co [1921] 2 AC 465, or s 13(4) of the Imprisonment for Debt Abolition Act 1874.
AD Instruments
AD Instruments are the manufacturers of MacLab‚Ñ¢, a scientific data recording and analysis system for the Apple Macintosh series. MacLab‚Ñ¢ comes in four and eight-channel forms, with Scope software which emulates a two-channel digital oscilloscope and Chart software to emulate an eight-channel chart recorder. Other packages include the Peaks chromatography workstation and the ElectroLab electrochemistry system. Specialised front-end amplifier modules are also available, such as the Bio Amplifier for human measurement applications and the Bridge Amplifier for force transducers. All MacLab software shares a consistent user interface and closely adheres to the Macintosh human interface standards.
